Seo Ree Kim (Seoree Kim)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

Combination Therapy

Locally Advanced

Top Venues

Korean journal of clinical oncology

Future oncology (London, England)

Journal of Korean medical science

Journal of gastric cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Seo Ree Kim, Yunseok Heo, Young-Ho Lee, Jin Hyoung Kang
Are 19del and L858R really different disease entities? Future oncology (London, England) (2024)
Seo Ree Kim, Sang Hoon Chun, Jong Youl Jin, Chung Hyun Tae, Junhyun Lee, Min-Sun Jin, Guk Jin Lee
Experience of serious intestinal hemorrhage and perforation in small bowel lymphoma: a case report. Korean journal of clinical oncology 17 (2) (2021)
Jae Ki Choi, Sunghan Kim, Seo Ree Kim, Jong Youl Jin, Seon Woong Choi, Hoon Kim, Jin-Hong Yoo, Ik Seong Park, Seong-Rim Kim
Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea. Journal of Korean medical science 36 (31) (2021)
Seo Ree Kim, Sang Hoon Chun, Jong Youl Jin, Chung Hyun Tae, Junhyun Lee, Min-Sun Jin, Guk Jin Lee
Experience of serious intestinal hemorrhage and perforation in small bowel lymphoma: a case report. Korean journal of clinical oncology 17 (2) (2021)
Seo Ree Kim, Kabsoo Shin, Jae Myung Park, Han-Hong Lee, Kyo Young Song, Sung Hak Lee, Bohyun Kim, Sang-Yeob Kim, Junyoung Seo, Jeong-Oh Kim, Sang-Young Roh, In-Ho Kim
Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer. Journal of gastric cancer 20 (4) (2020)
Seo Ree Kim, Sang Hoon Chun, Ji Hyun Kim, Sang-Yeob Kim, Bo In Lee, Chan-Kwon Jung, Jin Hyoung Kang
Clinical experience of immune checkpoint inhibitor for a metastatic jejunal cancer patient with a high tumor mutational burden and low expression of programmed death-ligand 1. Korean journal of clinical oncology 16 (1) (2020)
Seo Ree Kim, Sang Hoon Chun, Ji Hyun Kim, Sang-Yeob Kim, Bo In Lee, Chan-Kwon Jung, Jin Hyoung Kang
Clinical experience of immune checkpoint inhibitor for a metastatic jejunal cancer patient with a high tumor mutational burden and low expression of programmed death-ligand 1. Korean journal of clinical oncology 16 (1) (2020)